Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Nerve inflammation halts trial for Alzheimer's drug

Nerve inflammation halts trial for Alzheimer's drug news Progress in human Nerve inflammation halts genetics hindered by trial for Alzheimer’s drug reluctance to share David Adam Data sharing in human-genetics research is being hampered by concerns over intellectual property rights, says one of the first studies to try to quantify the problem. Of the 1,240 human geneticists surveyed by a team led by Eric Campbell of the Institute for Health Policy at Massachusetts General Hospital, Boston, almost half complained that a co-worker had refused them access to data, information or materials in the past three years. According to 28% of the survey respondents, such refusals meant that they could not replicate published work, and 58% felt that their own research had Before and after: plaques of amyloid-b (left) in mouse brain can be treated with the drug AN-1792. suffered as a result. The survey’s findings were published on 23 January in the Erika Check, Washington synthetic version of amyloid-b, and causes Journal of the American Medical the body’s immune system to attack amyloid- Trials of a new immunotherapy drug for Association (287, 473–480; 2002). Alzheimer’s disease have hit a roadblock, b plaques. But scientist say the autoimmune Requests for materials, such as cell response might also http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Nature Springer Journals

Nerve inflammation halts trial for Alzheimer's drug

Nature , Volume 415 (6871) – Jan 31, 2002

Nerve inflammation halts trial for Alzheimer's drug

Abstract

news Progress in human Nerve inflammation halts genetics hindered by trial for Alzheimer’s drug reluctance to share David Adam Data sharing in human-genetics research is being hampered by concerns over intellectual property rights, says one of the first studies to try to quantify the problem. Of the 1,240 human geneticists surveyed by a team led by Eric Campbell of the Institute for Health Policy at Massachusetts General Hospital, Boston, almost half complained that a co-worker had...
Loading next page...
 
/lp/springer-journals/nerve-inflammation-halts-trial-for-alzheimer-s-drug-0Zt0GHRdRD

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Springer Journals
Copyright
Copyright © Springer Nature Limited 2002
Subject
Science, Humanities and Social Sciences, multidisciplinary; Science, Humanities and Social Sciences, multidisciplinary; Science, multidisciplinary
ISSN
0028-0836
eISSN
1476-4687
DOI
10.1038/415462a
Publisher site
See Article on Publisher Site

Abstract

news Progress in human Nerve inflammation halts genetics hindered by trial for Alzheimer’s drug reluctance to share David Adam Data sharing in human-genetics research is being hampered by concerns over intellectual property rights, says one of the first studies to try to quantify the problem. Of the 1,240 human geneticists surveyed by a team led by Eric Campbell of the Institute for Health Policy at Massachusetts General Hospital, Boston, almost half complained that a co-worker had refused them access to data, information or materials in the past three years. According to 28% of the survey respondents, such refusals meant that they could not replicate published work, and 58% felt that their own research had Before and after: plaques of amyloid-b (left) in mouse brain can be treated with the drug AN-1792. suffered as a result. The survey’s findings were published on 23 January in the Erika Check, Washington synthetic version of amyloid-b, and causes Journal of the American Medical the body’s immune system to attack amyloid- Trials of a new immunotherapy drug for Association (287, 473–480; 2002). Alzheimer’s disease have hit a roadblock, b plaques. But scientist say the autoimmune Requests for materials, such as cell response might also

Journal

NatureSpringer Journals

Published: Jan 31, 2002

There are no references for this article.